Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine demethylase and nuclear receptor corepressor (HR, commonly known as "hairless") is a transcriptional corepressor and histone lysine demethylase enzyme encoded by the HR gene. It is involved in hair growth and skin biology through control of gene expression via demethylation of mono- and dimethylated lysine 9 on histone H3 and by acting as a corepressor of nuclear receptors (e.g., thyroid hormone receptor, retinoic acid receptor-related orphan receptor, and vitamin D receptor). Mutations in HR cause hereditary hypotrichosis and other genetic hair loss syndromes, with two primary isoforms known in humans. Its canonical role is an epigenetic regulator affecting hair development, cell cycle, and neural processes
No targeted clinical drugs; mechanistically, drugs targeting this molecule would presumably act via inhibition or modulation of its demethylase activity or transcriptional corepressor function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine demethylase and nuclear receptor corepressor (HR).